Investors Asset Management Of Georgia Inc Abb Vie Inc. Transaction History

Investors Asset Management Of Georgia Inc

  • $208 Million
  • Q3 2024

A detailed history of Investors Asset Management Of Georgia Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Investors Asset Management Of Georgia Inc holds 17,604 shares of ABBV stock, worth $3.17 Million. This represents 1.67% of its overall portfolio holdings.

Number of Shares
17,604
Previous 17,946 1.91%
Holding current value
$3.17 Million
Previous $3.08 Million 12.93%
% of portfolio
1.67%
Previous 1.52%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
SELL
$163.84 - $199.33 $56,033 - $68,170
-342 Reduced 1.91%
17,604 $3.48 Million
Q2 2024

Jul 29, 2024
SELL
$154.79 - $180.76 $12,692 - $14,822
-82 Reduced 0.45%
17,946 $3.08 Million
Q1 2024

Apr 22, 2024
SELL
$159.82 - $182.1 $27,169 - $30,957
-170 Reduced 0.93%
18,028 $3.28 Million
Q4 2023

Jan 31, 2024
SELL
$137.6 - $154.97 $19,264 - $21,695
-140 Reduced 0.76%
18,198 $2.82 Million
Q3 2023

Nov 09, 2023
BUY
$133.59 - $154.65 $34,733 - $40,209
260 Added 1.44%
18,338 $2.73 Million
Q2 2023

Aug 04, 2023
SELL
$132.51 - $164.9 $196,114 - $244,052
-1,480 Reduced 7.57%
18,078 $2.44 Million
Q1 2023

May 01, 2023
BUY
$144.61 - $166.54 $10,845 - $12,490
75 Added 0.38%
19,558 $3.12 Million
Q4 2022

Feb 02, 2023
SELL
$138.31 - $165.87 $32,226 - $38,647
-233 Reduced 1.18%
19,483 $3.15 Million
Q3 2022

Oct 27, 2022
BUY
$134.21 - $153.93 $67,776 - $77,734
505 Added 2.63%
19,716 $2.65 Million
Q2 2022

Aug 01, 2022
SELL
$137.62 - $174.96 $48,855 - $62,110
-355 Reduced 1.81%
19,211 $2.94 Million
Q1 2022

Apr 20, 2022
BUY
$131.98 - $163.75 $9,898 - $12,281
75 Added 0.38%
19,566 $3.17 Million
Q4 2021

Feb 03, 2022
SELL
$107.43 - $135.93 $8,594 - $10,874
-80 Reduced 0.41%
19,491 $2.64 Million
Q3 2021

Oct 14, 2021
BUY
$106.4 - $120.78 $206,948 - $234,917
1,945 Added 11.03%
19,571 $2.11 Million
Q2 2021

Jul 09, 2021
SELL
$105.21 - $117.21 $5,260 - $5,860
-50 Reduced 0.28%
17,626 $1.99 Million
Q1 2021

Apr 21, 2021
BUY
$102.3 - $112.62 $37,339 - $41,106
365 Added 2.11%
17,676 $1.91 Million
Q4 2020

Jan 28, 2021
SELL
$80.49 - $108.67 $38,232 - $51,618
-475 Reduced 2.67%
17,311 $1.86 Million
Q3 2020

Oct 14, 2020
BUY
$85.91 - $100.83 $4,295 - $5,041
50 Added 0.28%
17,786 $1.56 Million
Q2 2020

Jul 31, 2020
SELL
$73.37 - $98.18 $22,964 - $30,730
-313 Reduced 1.73%
17,736 $1.74 Million
Q1 2020

Apr 21, 2020
BUY
$64.5 - $97.79 $67,725 - $102,679
1,050 Added 6.18%
18,049 $1.38 Million
Q4 2019

Jan 15, 2020
SELL
$72.13 - $90.25 $32,458 - $40,612
-450 Reduced 2.58%
16,999 $1.51 Million
Q3 2019

Oct 17, 2019
BUY
$62.98 - $75.72 $9,447 - $11,358
150 Added 0.87%
17,449 $1.32 Million
Q2 2019

Jul 10, 2019
BUY
$65.7 - $83.98 $448,271 - $572,995
6,823 Added 65.13%
17,299 $1.26 Million
Q1 2019

Apr 17, 2019
BUY
$77.14 - $90.79 $4,628 - $5,447
60 Added 0.58%
10,476 $844,000
Q4 2018

Jan 22, 2019
SELL
$77.85 - $96.01 $24,522 - $30,243
-315 Reduced 2.94%
10,416 $960,000
Q3 2018

Oct 25, 2018
BUY
$88.91 - $98.84 $8,891 - $9,884
100 Added 0.94%
10,731 $1.02 Million
Q2 2018

Jul 27, 2018
BUY
$89.78 - $106.23 $50,635 - $59,913
564 Added 5.6%
10,631 $985,000
Q1 2018

Apr 11, 2018
SELL
$92.01 - $123.21 $23,002 - $30,802
-250 Reduced 2.42%
10,067 $953,000
Q4 2017

Jan 11, 2018
SELL
$89.56 - $98.21 $98,784 - $108,325
-1,103 Reduced 9.66%
10,317 $998,000
Q3 2017

Nov 02, 2017
BUY
$69.85 - $89.22 $797,686 - $1.02 Million
11,420
11,420 $1.02 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Investors Asset Management Of Georgia Inc Portfolio

Follow Investors Asset Management Of Georgia Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Asset Management Of Georgia Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investors Asset Management Of Georgia Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email